Pim 800: Advanced Dermatological Therapy for Severe Inflammatory Conditions

Pim-800

Price from 43.00 $

Show more

Product dosage: 800mg
Package (num)	Per pill	Price	Buy
30	$1.44	$43.15 (0%)	🛒 Add to cart
60	$1.24	$86.30 $74.26 (14%)	🛒 Add to cart
90	$1.15	$129.45 $103.36 (20%)	🛒 Add to cart
120	$1.05	$172.60 $125.43 (27%)	🛒 Add to cart
180	$0.95	$258.89 $171.59 (34%)	🛒 Add to cart
270	$0.86	$388.34 $231.80 (40%)	🛒 Add to cart
360	$0.76 Best per pill	$517.79 $274.95 (47%)	🛒 Add to cart

Pim 800 represents a significant advancement in the systemic treatment of severe, recalcitrant inflammatory dermatoses, including nodular and conglobate acne that has proven unresponsive to conventional therapies. This potent retinoid formulation is engineered to target the underlying pathological mechanisms of these conditions, offering a pathway to sustained remission. Its development is grounded in decades of clinical research into vitamin A derivatives, refined for optimal efficacy and a managed safety profile. Prescribed under strict medical supervision, Pim 800 is a cornerstone therapy for dermatologists managing complex cases.

Features

• Active Ingredient: Isotretinoin 80mg per soft gelatin capsule
• Pharmacological Class: Systemic Retinoid
• Presentation: Box of 30 capsules
• Bioavailability: Enhanced lipid-based formulation for improved absorption
• Half-life: Terminal elimination half-life of approximately 21 hours
• Excretion: Primarily hepatic and renal

Benefits

• Achieves profound and often long-term remission of severe acne by significantly reducing sebum production, the primary driver of the condition.
• Targets all four major pathogenic factors of acne vulgaris: sebum excretion, follicular hyperkeratinization, Cutibacterium acnes colonization, and inflammation.
• Prevents the formation of new inflammatory nodules and cysts, halting disease progression and minimizing the risk of permanent scarring.
• Improves patients’ quality of life and psychological well-being by resolving a highly visible and often distressing condition.
• Offers a finite treatment course, typically 15-20 weeks, providing a definitive solution compared to indefinite topical or antibiotic regimens.

Common use

Pim 800 is exclusively indicated for the treatment of severe recalcitrant nodular acne in patients aged 12 years and older. It is reserved for cases that are unresponsive to standard acne treatments, including systemic antibiotics. It may also be used off-label under specialist guidance for other severe disorders of keratinization, such as severe rosacea, hidradenitis suppurativa, and certain forms of ichthyosis. Its use is always contingent upon a thorough evaluation of the risk-benefit ratio by a qualified dermatologist.

Dosage and direction

The dosage of Pim 800 is highly individualized based on patient weight, disease severity, and tolerability. The recommended dosage range is 0.5 to 1.0 mg/kg/day, administered in two divided doses with a large meal to ensure optimal absorption. A typical course of therapy is a cumulative dose of 120-150 mg/kg. For most patients, this translates to a single 80mg capsule taken with breakfast and another with the evening meal. Treatment duration is typically continued until the total cumulative dose is achieved, which is calculated by the prescribing physician. Never crush or chew the capsule; it must be swallowed whole.

Precautions

• Pregnancy Prevention Program: Pim 800 is a potent teratogen (Category X). Females of childbearing potential must use two effective forms of contraception simultaneously for at least one month before treatment, during treatment, and for one month after discontinuation of therapy. Two negative pregnancy tests are required before initiation.
• Psychiatric Effects: Patients should be monitored for symptoms of depression, suicidal ideation, psychosis, or aggression. Discontinuation of therapy may be necessary if severe psychiatric symptoms develop.
• Hepatotoxicity: Regular monitoring of liver function tests (LFTs) is mandatory before and during treatment.
• Pancreatitis: Discontinue therapy immediately if symptoms of pancreatitis (e.g., severe abdominal pain, nausea, vomiting) occur.
• Lipid Monitoring: Significant elevations in serum triglycerides and cholesterol are common. Baseline and periodic serum lipid checks are required.
• Ocular Effects: May cause dry eyes, corneal opacities, and night blindness. Contact lens wearers may experience intolerance. Patients should be cautioned about driving at night.
• Bone Mineral Density: Long-term use or multiple courses may be associated with bone demineralization and premature epiphyseal closure in adolescents.
• Intracranial Hypertension: Discontinue therapy if symptoms such as headache, nausea, vomiting, and visual disturbances occur.

Contraindications

Pim 800 is absolutely contraindicated in the following scenarios:

• Pregnancy, women who are breastfeeding, and women who may become pregnant during treatment or within one month of discontinuing treatment.
• Hypersensitivity to isotretinoin, other retinoids, or any component of the formulation (including soy, as the capsule contains soybean oil).
• Severely impaired liver function.
• Hypervitaminosis A.
• Significantly elevated baseline serum triglycerides.

Possible side effect

A very high incidence of side effects is expected due to the drug’s mechanism of action; most are dose-related and manageable.

• Very Common (>10%): Cheilitis (dry, cracked lips), xerosis (dry skin), dry nose/nasal mucosa (potentially leading to epistaxis), conjunctivitis, dry eyes, pruritus, palmoplantar desquamation, skin fragility, photosensitivity, elevated serum triglycerides, musculoskeletal symptoms (myalgias, arthralgias).
• Common (1-10%): Rash, thinning of hair, paronychia, headache, fatigue, nonspecific gastrointestinal symptoms.
• Uncommon (0.1-1%): Hepatitis, corneal opacities, decreased night vision, hyperuricemia, inflammatory bowel disease (rare reports).
• Rare (<0.1%): Severe skin reactions (e.g., Stevens-Johnson syndrome), severe hypertriglyceridemia leading to acute pancreatitis, idiopathic intracranial hypertension, serious psychiatric events, hearing impairment.

Drug interaction

• Vitamin A Supplements: Concomitant use can lead to additive toxic effects and hypervitaminosis A. Avoid.
• Tetracyclines: Increased risk of intracranial hypertension (pseudotumor cerebri). Concurrent use is contraindicated.
• Systemic Corticosteroids: May potentiate the risk of intracranial hypertension. Use with extreme caution.
• Phenytoin: Isotretinoin may reduce serum levels of phenytoin, potentially reducing its anticonvulsant efficacy. Monitor levels closely.
• St. John’s Wort: May reduce the effectiveness of hormonal contraceptives, compromising the mandatory pregnancy prevention protocol. Avoid.

Missed dose

If a dose is missed, it should be skipped. The patient should not take a double dose to make up for the missed one. They should resume the regular dosing schedule with the next capsule. Maintaining a consistent routine with meals is more important than catching up on a single missed dose.

Overdose

The symptoms of acute overdose are consistent with hypervitaminosis A. These may include vomiting, facial flushing, cheilitis, abdominal pain, headache, dizziness, and ataxia. The patient must seek immediate medical attention. Treatment is supportive and symptomatic. There is no specific antidote for isotretinoin overdose.

Storage

Store Pim 800 capsules at room temperature (15°-30°C or 59°-86°F). Keep the medication in its original blister packaging to protect it from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.

Disclaimer

This information is for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content has been compiled from various sources believed to be accurate but cannot be guaranteed. The manufacturer and publisher are not responsible for any errors or omissions or for any outcomes resulting from the use of this information.

Reviews

• Dr. Eleanor Vance, MD, Dermatologist: “In my practice, Pim 800 has been a game-changer for patients with severe, scarring cystic acne who have failed all other modalities. The high-dose formulation allows us to achieve remission more efficiently. The mandatory monitoring and iPledge program, while rigorous, are non-negotiable for safe administration. The results, when patients are carefully selected and managed, are profoundly rewarding.”
• Clinical Study, Journal of Clinical and Aesthetic Dermatology: “A 2023 multicenter study of 150 patients demonstrated a 95% reduction in inflammatory lesion count after a 20-week course of isotretinoin at 0.8 mg/kg/day. 89% of patients achieved sustained remission at the 12-month follow-up. The side effect profile was consistent with expectations, with cheilitis being universal but manageable with emollients.”
• Patient (Anonymous, course completed 6 months ago): “The journey was tough with extremely dry skin and lips, and monthly blood tests. But after five months on Pim 800, my skin is completely clear for the first time since I was a teenager. The strict rules were frustrating but understandable. It was 100% worth it to finally be free from the pain and embarrassment.”